focus -WSS

focus

author：comprehensive 2025-09-30 20:46:54 - browse：132

Biogen announced a new round of cost cuts Tuesday, saying that it plans to save $700 million in operating costs and cut 1,000 jobs by 2025.

The company also released second quarter sales and earnings that handily topped the forecasts of Wall Street analysts. In early morning trading, Biogen shares rose more than 1%.

Biogen is attempting to recover from a series of corporate stumbles, the biggest of which involved the development and launch of the Alzheimer’s drug Aduhelm. The medicine was the first of a new class of disease-modifying Alzheimer’s drugs to be approved by the Food and Drug Administration. But doubts about the quality of the data behind the medicine meant that Medicare wouldn’t pay for it and doctors did not prescribe it. The resulting financial disaster cleaned out Biogen’s executive suite.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： FDA official pushes for dedicated emerging pathogens team

WSS

AbbVie dramatically boosts its spending on lobbying

Readout LOUD podcast: ESMO highlights & Roivant's big deal

Brain injuries and the importance of a second opinion

Live blog: Hearing on CRISPR

7 of the most gruesome medical devices in history

Court strikes down limits on filming of police in Arizona

entertainment

focus

focus

Cancer drug shortages should be causing more outrage

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Walensky prepares to leave CDC — and Congress — behind

Elizabeth Warren probes abortion access

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Key Senate panel to consider PBM, drug pricing reform package

Trump demands the U.S. pay no more for drugs than other countries … again

Artificial intelligence advances fuel industry trying to preserve loved ones after death

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Inari Medical to buy amputation prevention company LimFlow

Wikipedia

Humans aren't the only ones with an imagination. Rats have it too

Life sciences investors close nearly $6 billion in new funds

Why an extreme heat and wildfire smoke combination can be so dangerous

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Review: 'Barbie' will hit you like a shot in the heart

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

hotspot

entertainment

Wikipedia

Wikipedia